In this study, we find chemotherapy treatment to induce a CD133 and SPINK1 population in HCC and that Prom1-lineage ablation in HCC tumors results in a marked suppression of SPINK1 and can sensitize HCC cells to chemotherapy. The gene discussed is SPINK1; the disease is hepatocellular carcinoma.